Related Experiment Video
Updated: Jul 14, 2026
10:10
Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms
Published on: April 17, 2026
Primary retroperitoneal mucinous cystadenocarcinomas are a distinct entity
1Department of Gynecological Oncology, University Hospital Antwerp, Antwerp, Belgium. wiebren.tjalma@uza.be
Summary
Primary retroperitoneal mucinous cystadenocarcinomas are rare ovarian-type tumors. This case highlights their distinct entity and poor prognosis, similar to ovarian counterparts.
Area of Science:
- Gynecologic Oncology
- Pathology
- Surgical Oncology
Background:
- Primary retroperitoneal mucinous cystadenocarcinomas (PRMCs) are rare neoplasms with unclear origins.
- This report details a case of PRMC in a 74-year-old female patient.
Observation:
- The patient presented with a retroperitoneal cystic pelvic mass.
- Past surgical history included appendectomy, bilateral salpingo-oophorectomy, and hysterectomy.
- An exploratory laparotomy confirmed and completely excised the mass.
Findings:
- Histopathological analysis revealed a primary retroperitoneal mucinous cystadenocarcinoma, ovarian type.
- The patient received four cycles of carboplatin chemotherapy.
- Disease recurrence occurred after 8 months, with patient demise 31 months post-diagnosis.
Implications:
- PRMCs represent a distinct clinicopathological entity.
- These tumors share a similar poor prognosis to their ovarian counterparts.
- Further research into pathogenesis and treatment strategies for PRMCs is warranted.
